Biden weighs in on drug costs in US; The latest health stories from around the world

Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi  US President Joe Biden has stepped into a long-running debate about whether the National Institutes of Health (NIH) has legal authority to override an exclusive patent license granted to drug developers if they charge too much for treatments that relied on …

Biden weighs in on drug costs in US; The latest health stories from around the world Read More »